Large Cap Archives - Page 59 of 437

3 minute read

Major US Banks Top Q1 Earnings Estimates As High Interest Rates Offer Tailwinds: ‘Indicators Continue To Be Favorable,’ Jamie Dimon Says

April 12, 9:17 AM

JPMorgan, Wells Fargo, BlackRock, and Citigroup surpass Q1 2024 earnings and revenue forecasts, showing strong performance amidst high interest rates and a robust economy.

JPM

2 minute read

What’s Going On With Wells Fargo Shares After Beating Q1 Earnings?

By Nabaparna Bhattacharya

April 12, 8:40 AM

Wells Fargo reported Q1 earnings surpassing expectations, driven by increased noninterest income despite a decline in net interest income.

FTXO

2 minute read

What’s Going On With JPMorgan Shares Today?

By Lekha Gupta

April 12, 8:27 AM

JPMorgan Chase reported Q1 FY24 results with $42.5B net revenue, beating the consensus of $41.8B. CET1 capital ratio was 15.0% and net interest income increased by 11%.

IYF

1 minute read

What’s Going On With BP Shares Premarket Friday?

By Lekha Gupta

April 12, 7:42 AM

ADNOC reportedly considered buying BP, but decided it wasn't the right fit for their strategy. BP has underperformed and is seen as a potential takeover target.

2 minute read

BlackRock Starts Strong In 2024 With Q1 AUM & Fees Surge, Stock Gains

By Lekha Gupta

April 12, 7:22 AM

BlackRock, Inc. reported strong first-quarter results, with revenue up 11%, net inflow of $57 billion and adjusted EPS beating consensus. AUM increased to $10.5 trillion.

BLK

2 minute read

Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact

By Vandana Singh

April 11, 2:47 PM

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

ALPN

2 minute read

Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What’s Driving Markets Thursday?

By Piero Cingari

April 11, 2:13 PM

Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures within the basket.

ALPN

2 minute read

Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug

By Vandana Singh

April 11, 2:09 PM

The U.S. Justice Department accuses Regeneron Pharmaceuticals of Medicare fraud related to its macular degeneration drug, Eylea. Allegations include manipulating drug prices, resulting in inflated Medicare expenses.

REGN

2 minute read

Will Main Street Banks Outshine Wall Street In Q1 2024 Earnings?

By Piero Cingari

April 11, 2:06 PM

Major U.S. banks' Q1 2024 earnings reports will give crucial insights into the economy and consumer health. Analysts predict solid EPS and revenue for most banks.

BAC

2 minute read

Analyst Sees Volatile Future for North American Gas Prices, Upgrades Most Impacted Stock

By Lekha Gupta

April 11, 1:53 PM

Scotiabank analyst upgraded EQT, downgraded RRC & SWN due to revised forecasts for natural gas industry. Expects volatility & LNG export growth.

CHK